EnQuest PLC (LON:ENQ - Get Free Report) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 12.08 ($0.15) and traded as high as GBX 13.04 ($0.16). EnQuest shares last traded at GBX 13.04 ($0.16), with a volume of 3,221,921 shares.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group reduced their target price on EnQuest from GBX 30 ($0.37) to GBX 27 ($0.34) and set a "buy" rating on the stock in a report on Thursday, September 12th.
Get Our Latest Stock Analysis on EnQuest
EnQuest Price Performance
The stock has a market cap of £249.83 million, a PE ratio of -1,308.00, a price-to-earnings-growth ratio of 0.07 and a beta of 1.43. The company has a quick ratio of 0.75, a current ratio of 0.76 and a debt-to-equity ratio of 208.00. The company's fifty day moving average is GBX 11.60 and its 200 day moving average is GBX 12.07.
About EnQuest
(
Get Free Report)
EnQuest is providing creative solutions through the energy transition.
EnQuest is an independent energy company. We focus on mature late-life assets, responsibly optimising production to provide energy security. Where we can, we repurpose our infrastructure to deliver renewable energy and decarbonisation projects before executing world-class decommissioning.
Featured Articles
Before you consider EnQuest, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EnQuest wasn't on the list.
While EnQuest currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
